Diabetic Macular Edema Pathophysiology: Vasogenic versus Inflammatory

Area of Science:

• Ophthalmology
• Endocrinology
• Pathophysiology

Background:

• Diabetic macular edema (DME) is a leading cause of blindness in diabetic retinopathy (DR) patients.
• While good diabetes management (glycemia, blood pressure, lipids) is crucial, the exact pathological sequence leading to DME is not fully understood.
• Vascular endothelial growth factor (VEGF) is implicated, alongside angiogenesis and inflammation, but their causal relationship in DME pathogenesis remains unclear.

Purpose of the Study:

• To review current data on VEGF, angiogenesis, and inflammation in diabetic macular edema.
• To analyze the interdependent roles of angiogenesis and inflammation in DME development.
• To highlight the importance of understanding DME etiology for targeted therapies.

Main Methods:

• Literature review of existing data on VEGF, angiogenesis, and inflammation in DME.
• Analysis of the interplay between angiogenesis and inflammation in the context of DME pathogenesis.
• Discussion of current diagnostic limitations and future directions.

Main Results:

• Evidence suggests that angiogenesis and inflammation are interdependent in the development of DME.
• The precise sequence of events between VEGF-driven angiogenesis and inflammation requires further clarification.
• Current diagnostic methods cannot distinguish between angiogenic or inflammatory-dominant DME etiologies.

Conclusions:

• Angiogenesis and inflammation interact dynamically during DME development.
• Tailoring treatments, such as anti-VEGF or anti-inflammatory drugs, may depend on understanding individual DME pathophysiology.
• Future diagnostic advancements are needed to personalize DME treatment strategies based on underlying mechanisms.